Type
Closure
Country
France
Region
île de France; Essonne;
Location of affected unit(s)
Chilly-Mazarin
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

100 jobs
Number of planned job losses
Job loss
Announcement Date
10 July 2008
Employment effect (start)
10 July 2008
Foreseen end date
31 December 2009

Description

The management of Merck Serono, the German pharmaceutical group - specialized in diabetes - has announced that, at it fails to attract any buyer, it will close its plant at Chilly-Mazarin (Essonne) which currently employs 100. As part of its reorganisation plan, the group aims to refocus its activities on other therapeutic domains such as cancer, auto-immun deseases and so on. The closure calls a halt to a wider reorganization of the group initiated a few years ago. Six sites will remain in France, employing about 2,000 workers: Lyon, Monaco, Martillac (Gironde), Calais, Semoy (Loiret) and Meyzieu (Rhône).


Sources

  • 10 July 2008: Les Echos
  • : ()

Citation

Eurofound (2008), Merck Serono, Closure in France, factsheet number 66862, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66862.